The emergency department (ED) clinical approach to patients with unexplained syncope
has ushered in an era of advances in the point-of-care ultrasound (POCUS) practice.
Cardiac ultrasound (US) is a key application that is often utilized in young patients
with syncope when screening for structural abnormalities such as hypertrophic cardiomyopathy
(HCM). The application of the cardiac US for this screening, however, can be hindered
by phenotypic variability of hereditary HCM. The apical variant of HCM constitutes
a minority of all cases (<3%) and is generally associated with a benign prognosis.
We describe a 28-year-old woman and former collegiate middle-distance/endurance runner
who presented to the emergency department (ED) with syncope. Earlier in the day, she
was one mile into a planned ten-mile run, when she reached an intersection requiring
her to stop. Upon stopping abruptly, she experienced a feeling of warmth, followed
by shortness of breath, blurred vision and subsequent loss of consciousness. The patient
had syncopized several times before in her life—all in the setting of abruptly stopping
after a warm-up exercise. She denied any other complaints and had no other relevant
past medical history. Family history was notable for myocardial infarction (MI) in
the patient's father while he was in his 50s, as well as sudden cardiac death of her
paternal grandfather while he was also in his 50s. Upon arrival to the ED, blood pressure
was 93/59 mm Hg; heart rate, 59 beats per minute; oxygen saturation, 99% on room air,
and temperature 98.4 F. On examination, the patient was well appearing, alert, oriented
and in no acute distress. Orthostasis was not present. Breath sounds were clear and
equal bilaterally. Cardiac examination demonstrated regular rhythm without murmur,
rub or gallop. Distal pulses were intact and jugular venous distension was absent.
To read this article in full you will need to make a payment
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Hypertrophic cardiomyopathy: clinical update.JACC Heart Fail. 2018 May; 6: 364-375
- Apical hypertrophic cardiomyopathy.World J Cardiol. 2011 Jul 26; 3: 256-259
- Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy.Circ Res. 2017 Sep 15; 121: 749-770
- American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: Endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography.J. Am. Soc. Echocardiogr. 2011 May; 24: 473-498
- Images in clinical medicine. Apical hypertrophic cardiomyopathy.N Engl J Med. 2015 Nov 5; 373e22
- The role of cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.Rev Cardiovasc Med. 2016; 17: 57-64
Article Info
Publication History
Published online: February 01, 2019
Accepted:
January 31,
2019
Received:
January 31,
2019
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.